Wang Ting, Girgis Safwat, Chang Hsiu-Ju, Assi Ali, Fagan-Garcia Katharine, Cromarty Taylor, Munday Rachel, Goodman Karen J, Veldhuyzen van Zanten Sander
Department of Medicine, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, AB T6G 2X8, Canada.
Department of Lab Medicine & Pathology, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, AB T6G 2X8, Canada.
Cancers (Basel). 2023 Aug 3;15(15):3950. doi: 10.3390/cancers15153950.
Community-driven projects have characterized () infection in Indigenous communities in the Northwest Territories (NT) and Yukon (YT), Canada. These projects address concerns about the frequent diagnosis of infection among community members and its relation to gastric cancer deaths, perceived to occur with alarming frequency in this region. Projects included breath-test screening for infection, gastroscopy with gastric biopsies, and treatment to eliminate infection. Previous project results showed a high prevalence of stomach pathologies associated with increased cancer risk among -positive participants at baseline. This analysis describes changes in precancerous gastric pathologies in project participants who had gastroscopy before baseline treatment during 2008-2013 and again in 2017. Throughout the study period, the same pathologist graded density, active gastritis, chronic gastritis, atrophic gastritis, and intestinal metaplasia using the updated Sydney System. Of 310 participants from three communities with baseline pathology data, 69 had follow-up pathology data. Relative to baseline, the prevalence of infection and precancerous gastric pathology was substantially lower at follow-up; most participants who were -positive at baseline and -negative at follow-up had reduced severity of active, chronic, and/or atrophic gastritis at follow-up. Though follow-up numbers are small, these results yield evidence that successful treatment has the potential to reduce the risk of gastric cancer in Arctic Indigenous communities.
社区主导的项目已成为加拿大西北地区(NT)和育空地区(YT)原住民社区幽门螺杆菌感染的特征。这些项目解决了社区成员中幽门螺杆菌感染的频繁诊断及其与胃癌死亡的关系问题,该地区胃癌死亡的发生率令人担忧。项目包括幽门螺杆菌感染的呼气试验筛查、胃镜检查及胃活检,以及消除幽门螺杆菌感染的治疗。此前项目结果显示,基线时幽门螺杆菌检测呈阳性的参与者中,与癌症风险增加相关的胃部病变患病率很高。本分析描述了2008 - 2013年基线治疗前接受胃镜检查且2017年再次接受检查的项目参与者癌前胃部病变的变化情况。在整个研究期间,同一位病理学家使用更新后的悉尼系统对幽门螺杆菌密度、活动性胃炎、慢性胃炎、萎缩性胃炎和肠化生进行分级。在310名来自三个社区且有基线病理数据的参与者中,69人有随访病理数据。与基线相比,随访时幽门螺杆菌感染和癌前胃部病变的患病率大幅降低;大多数基线时幽门螺杆菌检测呈阳性而随访时呈阴性的参与者,随访时活动性、慢性和/或萎缩性胃炎的严重程度有所减轻。尽管随访人数较少,但这些结果证明,成功的幽门螺杆菌治疗有可能降低北极原住民社区患胃癌的风险。